4.7 Article

In vivo administration of extracellular cGMP normalizes TNF-α and membrane expression of AMPA receptors in hippocampus and spatial reference memory but not IL-1β, NMDA receptors in membrane and working memory in hyperammonemic rats

Journal

BRAIN BEHAVIOR AND IMMUNITY
Volume 57, Issue -, Pages 360-370

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2016.05.011

Keywords

Extracellular cGMP; Neuroinflammation; Spatial learning; IL-1 beta; TNIF-alpha; NMDA receptors; AMPA receptors; Membrane expression; Working memory; Reference memory

Funding

  1. Ministerio de Ciencia e Innovacion - Spain [SAF2011-23051, CSD2008-00005, SAF2014-51851-R]
  2. Ministerio de Educacion de la Nacion - Spain [FPU13/02492]
  3. Generalitat Valenciana [PROMETEO-2009-027, PROMETEOII/2014/033]
  4. European Regional Development Funds (ERDF)

Ask authors/readers for more resources

Patients with hepatic encephalopathy.(HE) show working memory and visuo-spatial orientation deficits. Hyperammonemia is a main contributor to cognitive impairment in HE. Hyperammonemic rats show impaired spatial learning and learning ability in the Y maze. Intracerebral administration of extracellular cGMP restores learning in the Y-maze. The underlying mechanisms remain unknown. It also remains unknown whether extracellular cGMP improves neuroinflammation or restores spatial learning in hyperammonemic rats and if it affects differently reference and working memory. The aims of this work were: a) assess whether treatment with extracellular cGMP reduces hippocampal neuroinflammation and restores spatial learning in hyperammonemic rats. b) analyze the underlying mechanisms, including changes in membrane expression of NMDA and AMPA receptors. Spatial working and reference memory were assessed using the radial and Morris water mazes and neuroinflammation by immunohistochemistry and Western blot. Membrane expression of NMDA and AMPA receptor subunits was analyzed using the BS3 crosslinker. Extracellular cGMP was administered intracerebrally using osmotic minipumps. Chronic hyperammonemia induces neuroinflammation in hippocampus, with astrocytes activation and increased IL-1 beta, which are associated with increased NMDA receptors membrane expression and impaired working memory. This process is not affected by extracellular cGMP. Hyperammonemia also activates microglia and increases TNF-alpha, alters membrane expression of AMPA receptor subunits (increased GluA1 and reduced GluA2) and impairs reference memory. All these changes are reversed by extracellular cGMP. These results show that extracellular cGMP modulates spatial reference memory but not working memory. This would be mediated by modulation of TNF-alpha levels and of membrane expression of GluA1 and GluA2 subunits of AMPA receptors. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

The S1PR2-CCL2-BDNF-TrkB pathway mediates neuroinflammation and motor incoordination in hyperammonaemia

Yaiza M. Arenas, Tiziano Balzano, Gergana Ivaylova, Marta Llansola, Vicente Felipo

Summary: Chronic hyperammonaemia induces neuroinflammation and motor incoordination in hepatic encephalopathy, and this study identifies the involvement of the S1PR2-CCL2-BDNF-TrkB pathway. Blocking S1PR2 can alleviate neuroinflammation and restore motor coordination.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Review Pharmacology & Pharmacy

Neuroinflammation, immune response and α-synuclein pathology: how animal models are helping us to connect dots

Tiziano Balzano, Noelia Esteban-Garcia, Javier Blesa

Summary: A key event in Parkinson's disease is the spreading of alpha-synuclein between neurons. Other characteristics of the disease include neurodegeneration, glial activation, and immune cell infiltration in vulnerable brain regions. Preclinical models can mimic most aspects of Parkinson's disease, but understanding individual differences between models is crucial for proper interpretation of results and influencing experimental outcomes.

EXPERT OPINION ON DRUG DISCOVERY (2023)

Article Immunology

Extracellular vesicles from mesenchymal stem cells reduce neuroinflammation in hippocampus and restore cognitive function in hyperammonemic rats

Paula Izquierdo-Altarejos, Andrea Cabrera-Pastor, Mar Martinez-Garcia, Carlos Sanchez-Huertas, Alberto Hernandez, Victoria Moreno-Manzano, Vicente Felipo

Summary: Chronic hyperammonemia leads to neuroinflammation, causing cognitive impairment. Extracellular vesicles from mesenchymal stem cells can reduce neuroinflammation. In this study, it was found that treatment with these vesicles restores cognitive function in hyperammonemic rats and the underlying mechanism involves TGF beta signaling.

JOURNAL OF NEUROINFLAMMATION (2023)

Article Biochemistry & Molecular Biology

Extracellular vesicles from hyperammonemic rats induce neuroinflammation in hippocampus and impair cognition in control rats

Paula Izquierdo-Altarejos, Mar Martinez-Garcia, Vicente Felipo

Summary: Patients with liver cirrhosis may experience cognitive impairment due to hyperammonemia and peripheral inflammation, which can also be replicated in rats with chronic hyperammonemia. Neuroinflammation in the hippocampus, caused by peripheral inflammation, alters neurotransmission and leads to cognitive impairment. Extracellular vesicles (EVs) from peripheral blood are believed to play a role in transmitting these peripheral alterations to the brain.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Article Clinical Neurology

Patients who died with steatohepatitis or liver cirrhosis show neuroinflammation and neuronal loss in hippocampus

Paola Leone, Yaiza M. Arenas, Tiziano Balzano, Gergana Mincheva, Mar Martinez-Garcia, Carmina Montoliu, Marta Llansola, Vicente Felipo

Summary: This study investigated the presence of neuroinflammation, apoptosis, and neuronal loss in the hippocampus of patients with liver cirrhosis and steatohepatitis. The results showed that patients with steatohepatitis exhibited glial activation, immune cell infiltration, apoptosis, and neuronal loss, while cirrhotic patients only showed glial activation and neuronal loss. These findings may explain the irreversible cognitive impairments observed in hepatic encephalopathy.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease

Alessandra Fiorillo, Juan-Jose Gallego, Franc Casanova-Ferrer, Carla Gimenez-Garzo, Amparo Urios, Maria-Pilar Ballester, Lucia Durban, Maria-Pilar Rios, Javier Megias, Teresa San Miguel, Elena Kosenko, Desamparados Escudero-Garcia, Salvador Benlloch, Vicente Felipo, Carmina Montoliu

Summary: Patients with NAFLD may experience mild cognitive impairment (MCI), and this study identified specific alterations in the immune system that are associated with neurological changes in MCI patients with NAFLD, which may help improve and restore cognitive functions and quality of life in these patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Neurosciences

Sustained Hyperammonemia Activates NF-κB in Purkinje Neurons Through Activation of the TrkB-PI3K-AKT Pathway by Microglia-Derived BDNF in a Rat Model of Minimal Hepatic Encephalopathy

Yaiza M. Arenas, Vicente Felipo

Summary: Chronic hyperammonemia is a major cause of cognitive and motor impairment in hepatic encephalopathy patients. This study aimed to investigate the mechanism involving BDNF, TrkB, NF-kappa B, and various proteins in hyperammonemic rats. The results showed that increased BDNF levels enhanced TrkB activation, leading to PI3K-AKT-NF-kappa B pathway activation and increased content of glutaminase I, HMGB1, and TNF alpha. Blocking TrkB, PI3K, or components of the TNFR1-S1PR2-CCR2-BDNF-TrkB pathway reversed these changes. This TrkB-PI3K-AKT-NF-kappa B pathway activation may contribute to Purkinje neuron dysfunction and motor impairment in hyperammonemic rats and cirrhotic patients with hepatic encephalopathy.

MOLECULAR NEUROBIOLOGY (2023)

Review Biochemistry & Molecular Biology

Active Clinical Trials in Hepatic Encephalopathy: Something Old, Something New and Something Borrowed

Tiziano Balzano

Summary: Hepatic encephalopathy (HE) is a reversible neurocognitive syndrome in patients with liver disease. Current therapies focus on reducing ammonia production or increasing its elimination. Only lactulose and rifaximin have been approved for HE treatment, while other potential treatments are limited. This review summarizes ongoing clinical trials for HE treatment, with most agents in phase II or III. These include familiar drugs like lactulose and rifaximin, as well as new entries like fecal microbiota transplantation and equine anti-thymocyte globulin. If successful, these drugs could provide alternative options for ineffective therapies and improve the quality of life for HE patients.

NEUROCHEMICAL RESEARCH (2023)

Article Multidisciplinary Sciences

BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients: Targeted AAV vector delivery and PET imaging

Javier Blesa, Jose A. Pineda-Pardo, Ken-ichi Inoue, Carmen Gasca-Salas, Tiziano Balzano, Natalia Lopez-Gonzalez Del Rey, Alejandro Reinares-Sebastian, Noelia Esteban-Garcia, Rafael Rodriguez-Rojas, Raquel Marquez, Maria Ciorraga, Marta del Alamo, Lina Garcia-Canamaque, Santiago Ruiz de Aguiar, Itay Rachmilevitch, Ines Trigo-Damas, Masahiko Takada, Jose A. Obeso

Summary: Successful blood-brain barrier opening and targeted delivery of adeno-associated virus serotype 9 vectors into brain regions involved in Parkinson's disease were achieved using low-intensity focused ultrasound. Neuronal green fluorescent protein expression was observed specifically in regions with confirmed blood-brain barrier opening. This less-invasive methodology could potentially revolutionize gene therapy for neurodegenerative disorders.

SCIENCE ADVANCES (2023)

Review Pharmacology & Pharmacy

Hepatic encephalopathy: investigational drugs in preclinical and early phase development

Tiziano Balzano, Marta Llansola, Yaiza M. Arenas, Paula Izquierdo-Altarejos, Vicente Felipo

Summary: Hepatic encephalopathy is a neuropsychiatric syndrome associated with liver disease. Current treatments primarily focus on modulating gut microbiota or reducing ammonia levels, but their effectiveness is limited. Pre-clinical research suggests that targeting peripheral inflammation, neuroinflammation, or neurotransmission may provide new therapeutic options for HE. However, there is a lack of translation of research advances into clinical trials.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2023)

Article Gastroenterology & Hepatology

Golexanolone improves fatigue, motor incoordination and gait and memory in rats with bile duct ligation

Yaiza M. Arenas, Paula Izquierdo-Altarejos, Mar Martinez-Garcia, Carla Gimenez-Garzo, Gergana Mincheva, Magnus Doverskog, David E. J. Jones, Tiziano Balzano, Marta Llansola, Vicente Felipo

Summary: Golexanolone treatment may have beneficial effects in improving fatigue, motor, and cognitive impairment in patients with the chronic cholestatic liver disease PBC.

LIVER INTERNATIONAL (2023)

Meeting Abstract Clinical Neurology

A mouse model to test the cortical pathogenic theory of Parkinson's disease

M. Moreno-Gomez, D. Humanes-Valera, J. Pardo-Valencia, N. Mercado-Garcia, B. Pro-Sanchez, A. Revuelto-Gonzalez, T. Balzano, J. Blesa, A. Bortolozzi, J. A. Obeso, G. Foffani

MOVEMENT DISORDERS (2022)

Letter Immunology

Reply to letter by Dr. Fu and Dr. Chu: Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders

Wan-Ju Cheng, Hong-Mo Shih, Kuan-Pin Su, Po-Ren Hsueh

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Cognitive, behavioral, neuroimaging and inflammatory biomarkers after hospitalization for COVID-19 in Brazil

Felipe Kenji Sudo, Talita P. Pinto, Fernanda G. Q. Barros-Aragao, Ivanei Bramati, Theo F. Marins, Marina Monteiro, Fernanda Meireles, Rejane Soares, Pilar Erthal, Victor Calil, Naima Assuncao, Natalia Oliveira, Joana Bondarovsky, Camila Lima, Beatriz Chagas, Alana Batista, Julia Lins, Thais L. Pinheiro, Felippe Mendonca, Andrea Silveira de Souza, Fernanda C. Rodrigues, Gabriel R. de Freitas, Pedro Kurtz, Paulo Mattos, Erika C. Rodrigues, Fernanda G. De Felice, Fernanda Tovar-Moll

Summary: Post-COVID-19 Condition (PCC) is a multisystemic syndrome that persists for months after SARS-CoV-2 infection, affecting cognitive function and neuropsychiatric features. A study on COVID-19 survivors in Brazil found that these patients experienced significant difficulties in overall cognition, memory, working memory, and inhibitory control, as well as fatigue, anxiety, and depressive symptoms. In addition, elevated levels of inflammatory markers in the blood were associated with brain microstructural damage and cognitive impairments.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Chemogenetic approaches reveal dual functions of microglia in seizures

Aastha Dheer, Dale B. Bosco, Jiaying Zheng, Lingxiao Wang, Shunyi Zhao, Koichiro Haruwaka, Min-Hee Yi, Abhijeet Barath, Dai-Shi Tian, Long-Jun Wu

Summary: Microglial activation plays a crucial role in the pathology of epilepsy, with both acute and prolonged activation affecting seizure severity and neuronal loss.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Maternal inflammation during pregnancy is associated with risk of ADHD in children at age 10

Julie B. Rosenberg, Jens Richardt Mollegaard Jepsen, Parisa Mohammadzadeh, Astrid Sevelsted, Rebecca Vinding, Mikkel E. Sorensen, David Horner, Kristina Aagaard, Birgitte Fagerlund, Susanne Brix, Nilofar Folsgaard, Ann -Marie M. Schoos, Jakob Stokholm, Bo Chawes, Christos Pantelis, Soren Dalsgaard, Birte Y. Glenthoj, Niels Bilenberg, Klaus Bonnelykke, Bjorn H. Ebdrup

Summary: Clinical data demonstrates a strong association between prenatal maternal inflammation assessed by hs-CRP and a diagnosis of ADHD by age 10. Maternal inflammation is also associated with ADHD symptom load in the entire cohort.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Voluntary wheel running prevents formation of membrane attack complexes and myelin degradation after peripheral nerve injury

Suzanne M. Green-Fulgham, Michael J. Lacagnina, Kendal F. Willcox, Jiahe Li, Michael E. Harland, Adriano Polican Ciena, Igor R. Correia Rocha, Jayson B. Ball, Renee A. Dreher, Younus A. Zuberi, Joseph M. Dragavon, Marucia Chacur, Steven F. Maier, Linda R. Watkins, Peter M. Grace

Summary: Regular aerobic activity, specifically voluntary wheel running, can reduce the risk of chronic pain by inhibiting MAC and preserving myelin integrity at the site of peripheral nerve injury.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Neuronanomedicine for Alzheimer's and Parkinson's disease: Current progress and a guide to improve clinical translation

India Boyton, Stella M. Valenzuela, Lyndsey E. Collins-Praino, Andrew Care

Summary: Neuronanomedicine is a multidisciplinary field that aims to develop innovative nanotechnologies for the treatment of neurodegenerative disorders. Nanoparticles are an important component of neuronanomedicine, as they can improve drug properties and enhance safety and delivery across the blood-brain barrier. However, a major challenge for neuronanomedicine translation is the poor understanding of bio-nano interactions, partly due to inconsistent reporting in published works. This review provides specific recommendations to guide researchers in harnessing the unique properties of nanoparticles for breakthrough treatments of Alzheimer's and Parkinson's disease.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Mind versus body: Perceived stress and biological stress are independently related to cognitive decline

Celine De Looze, Cathal McCrory, Aisling O'Halloran, Silvia Polidoro, Rose Anne Kenny, Joanne Feeney

Summary: Our study found that subjective measures of stress and biological metrics may be independently associated with cognitive function over time in older adults, hinting at potential different underlying mechanisms.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Choroid plexus volume is increased in mood disorders and associates with circulating inflammatory cytokines

Beatrice Bravi, Elisa Maria Teresa Melloni, Marco Paolini, Mariagrazia Palladini, Federico Calesella, Laura Servidio, Elena Agnoletto, Sara Poletti, Cristina Lorenzi, Cristina Colombo, Francesco Benedetti

Summary: Depressed patients show changes in immune-inflammatory markers in their blood and cerebrospinal fluid. The Choroid Plexus, located at the base of the brain ventricles, plays a key role in regulating the exchange of substances between the brain and immune cells. Patients with bipolar disorder or major depressive disorder have larger Choroid Plexus volumes compared to healthy controls. Age and levels of circulating cytokines are associated with Choroid Plexus volumes in the clinical groups.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis

Mingxuan Zheng, Huaiyu Ye, Xiaoying Yang, Lijun Shen, Xuemei Dang, Xiaoli Liu, Yuying Gong, Qingyuan Wu, Li Wang, Xing Ge, Xiaoli Fang, Benchi Hou, Peng Zhang, Renxian Tang, Kuiyang Zheng, Xu-Feng Huang, Yinghua Yu

Summary: Obesity is linked to cognitive dysfunction and neurodegenerative disease. The connection between the gut microbiota and the brain is altered in obesity. The probiotic Clostridium butyricum can improve cognitive impairment caused by obesity and prevent gut microbiota dysbiosis and inflammation.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Stem-cell derived neurosphere assay highlights the effects of viral infection on human cortical development

Edward Drydale, Phalguni Rath, Katie Holden, Gregory Holt, Laurissa Havins, Thomas Johnson, James Bancroft, Lahiru Handunnetthi

Summary: This study created a novel three-dimensional neurosphere assay using induced pluripotent stem cell differentiation and live cell imaging techniques to investigate the effect of a simulated viral infection on cortical development. The findings demonstrated that the infection led to reduced radial glial growth and neural migration.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

An integral blood-brain barrier in adulthood relies on microglia-derived PDGFB

Yuancheng Weng, Ningting Chen, Rui Zhang, Jian He, Xukai Ding, Guo Cheng, Qianqian Bi, Ying-mei Lu, Xiao Z. Shen, Shu Wan, Peng Shi

Summary: This study reveals that microglia is the primary cellular source of PDGFB in adults, and microglial PDGFB is crucial for maintaining BBB integrity in adult mice.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Gonadal hormones impart male-biased behavioral vulnerabilities to immune activation via microglial mitochondrial function

Evan A. Bordt, Haley A. Moya, Young Chan Jo, Caitlin T. Ravichandran, Izabella M. Bankowski, Alexis M. Ceasrine, Christopher J. Mcdougle, William A. Carlezon Jr, Staci D. Bilbo

Summary: There is a strong male bias in many neurodevelopmental disorders such as autism spectrum disorder, but the mechanisms behind this bias are unknown. Infection during the perinatal period increases the risk of neurodevelopmental disorders. Using a mouse model, researchers found that early-life immune activation only induced deficits in social behaviors in male mice. These behavioral changes were associated with alterations in microglial immune signaling, mitochondrial morphology, gene expression, and function specifically in microglia, the brain's innate immune cells. Furthermore, the vulnerability to early-life immune activation and its effects on behavior and microglial mitochondria were programmed by the male-typical perinatal gonadal hormone surge. These findings highlight the role of microglia-specific mechanisms shaped by early developmental events in regulating male social behavior throughout lifespan.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Interleukin-15 alters hippocampal synaptic transmission and impairs episodic memory formation in mice

Maria Amalia Di Castro, Stefano Garofalo, Alessandro Mormino, Laura Carbonari, Erika Di Pietro, Eleonora De Felice, Myriam Catalano, Laura Maggi, Cristina Limatola

Summary: Cytokines, such as interleukin-15 (IL-15), play important roles in modulating the central nervous system (CNS). In this study, the authors found that exposure to IL-15 enhances GABA release and reduces glutamatergic currents in hippocampal slices. Chronic treatment with IL-15 has negative effects on memory formation. Serotonin is involved in mediating these effects, as a selective 5-HT3A receptor antagonist prevents the effects on inhibitory neurotransmission and improves performance in a memory test.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Comprehensive immunoprofiling of neurodevelopmental disorders suggests three distinct classes based on increased neurogenesis, Th-1 polarization or IL-1 signaling

Nikhitha Sreenivas, Michael Maes, Hansashree Padmanabha, Apoorva Dharmendra, Priyanka Chakkera, Saptamita Paul Choudhury, Fazal Abdul, Thrinath Mullapudi, Vykuntaraju K. Gowda, Michael Berk, John Vijay Sagar Kommu, Monojit Debnath

Summary: Neurodevelopmental disorders (NDDs) are a spectrum of conditions with both common and differing characteristics in terms of phenome, symptomatome, neuropathology, risk factors and underlying mechanisms. This study investigates the possibility of a shared immune etiology among three early-onset NDDs, namely Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD) and Intellectual Disability Disorder (IDD).

BRAIN BEHAVIOR AND IMMUNITY (2024)